Home › Cohorts › Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Pati

Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Pati PCEC05A34C

4 studies · 800 curated samples · 0 distinct subject identifiers · 2 shared papers. Grouping rule: shared own-data paper.

Samples CSV (23.4 KB) parquet (102.2 KB) Flag an issue

Age categories

adult	441
elderly	189
unknown	169
neonate	1

Countries

800

Health conditions

other_cancer Other cancer (incl. immunotherapy cohorts)	230
healthy_control Healthy / control	159
other_disease Other disease / condition	116
obesity Obesity / overweight	63
ibs Irritable bowel syndrome	51
crohns_disease Crohn's disease	3

Studies

study	title	samples	source
PRJNA1116523	Microbial and metabolic gut profiling across seven malignancies identifies fecal Faecalibacillus intestinalis and formic acid as commonly altered in cancer patients	387	gut_all_v1
PRJNA885289	Characteristics of the gut microbiome in esports players compared with those in physical education students and professional athletes	169	gut_all_v1
PRJNA1001944	Breast cancer but not the menopausal status is associated with small changes of the gut microbiota	153	gut_all_v1
PRJNA1125836	Gut microbiome obesity index, a new analytical part of the metagenomics workflow to evaluate gut dysbiosis in obese humans	91	gut_all_v1

Shared papers

Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients. — PMID 39125593 · PMC11311272 · doi · studies: PRJNA1001944, PRJNA1116523, PRJNA885289
The Gut Microbiome Obesity Index: A New Analytical Tool in the Metagenomics Workflow for the Evaluation of Gut Dysbiosis in Obese Humans — PMID 40732945 · PMC12298630 · doi · studies: PRJNA1125836, PRJNA885289